An AI tool that identifies patients at risk of lung cancer from their clinical history could help GPs refer them for tests ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

A recent study from Karolinska Institutet identifies specific blood biomarkers linked to long COVID, particularly in patients ...

How much did they smoke? Were they exposed to smoke from others? Were they born prematurely? Did they experience a lot of ...

Birmingham Vasculitis Activity Scores (BVAS) were used to identify disease manifestations. Key efficacy outcomes included remission at week 26, sustained remission at week 52, relapse rates, the ...

Karachi is witnessing a sharp rise in cases of Bird Fancier’s Lung, a rare respiratory illness caused by exposure to airborne ...

Dr. Bryant Lin explains how his stage IV lung cancer diagnosis didn’t defeat him but instead inspired a revolutionary class.

Preliminary results from the AACR 2025 Annual Meeting reveal encouraging clinical responses to the investigational oral agent ...

The Phase II trial will assess the therapy’s safety, tolerability and its activity across various biomarkers in IPF patients.

Branwen Hywel, from Anglesey, was diagnosed with stage 3 lung cancer in 2018 - 18 months after first experiencing symptoms. | ITV News Wales ...

UVA researchers discover distinct immune changes in Long COVID survivors, offering hope for targeted therapies.